- Report
- October 2025
- 160 Pages
Global
From €3467EUR$3,950USD£3,017GBP
Aveed is a brand of endocrine and metabolic disorder drugs used to treat a variety of conditions, including hypogonadism, growth hormone deficiency, and Cushing's syndrome. It is a long-acting injectable testosterone ester, which is administered intramuscularly. Aveed is designed to provide a steady release of testosterone over a period of several weeks, allowing for fewer injections and improved patient compliance. Aveed is also used off-label to treat male infertility, delayed puberty, and other conditions.
The Aveed market is highly competitive, with a number of major pharmaceutical companies offering similar products. These include AbbVie, Pfizer, Merck, Novartis, and Sanofi. Other companies, such as Endo Pharmaceuticals, also offer Aveed-branded products. Show Less Read more